FDA Investigator Igbinoba

Igbinoba has inspections in 1 countries as of 19 Sep 2023. Igbinoba has collaborated with a combinined 2022 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
1080
Last Inspection Date:
19 Sep 2023
Investigator Role:
FDA Investigator (Contractor)
Redica ID:
Country:
United States of America
Co-Investigator(s):
Aaron P Wozniak, Abdur Rashid, Adam J Williams, Alaric C Denton, Alphonso A Haupt, III, Amanda L Evanco, Anthony S Puckett, Arie R Dyk, Arlyss M Jones, Arthur G Hurst, Babatunde D Babalola, Bernadette T Tallman, Betsy C Galliher, Bevill, Billy M Battles, Bolden, Brandy D Brown, Bridegan, Brown, Brownk, Buford, Burnell M Henry, Carlos A Ortiz, Carol J Blackwood, CDR Thomas R Berry, PPh, Chapman, Cheryl D Barton, Chestnut, Christina H Owens, Christine M O'leary, Christopher C Wilcox, Contractor Bridgers, Cordelia J Brammer, David P Moorhead, David Williams, Davis, Debra J Tucker, Dellarese L Herbert, Derek C Price, Devaughn Edwards, Donald L Zink, Douglas Brogden B, Edward Deberry, Ernest H Blackwood, Gabriel R Mclemore, Gary E Coleman, Jr, REHS, Gray, Hansford, Harmon, Heather Akleimola Hulbert, Heather M Wheeler, Hristu B Chepa, Hudson, Ingrid A Zambrana, Ivery, Jack Wvan Stavern, Jackie M Douglas, James P Lewis, Jr, Janet B Gray, Jawaid Hamid, Jessica E Gore, Jhakeim D Seaberry, Joe A Odom, John D Lloyd, John E Aghadia, John Stackman, Johnson, Jones, Joshua C Schafer, Karen L Anderson, Kathryn A Nagy, Kenny R Robinson, Keri U Walker, Kewes, Kimberly Kroesen, Laura D Cain, Lawrence, Lawrence S Newsom, Lawrence Thomas, Lesley K Satterwhite, Mancia R Walker, Marie F Morin, Matthew G Brown, Mcbean, Myla D Chapman, Nancy E Fontaine, Nelson A Rodriguez, Patricia F Hudson, Paula J Bretz, Perry H Gambrell, Rachael Lucinski, Randy L Clarida, Rashard A Knight, Rashonda N Rucker, Richard L Garcia, Robert J Rutherford, Robert P Neligan, Robert W Turner, Robertson, Robin N Goins, Russell R Zablan, Sally Gopaul, Sameerah K Abdur Rashid, Samuel A Hamblin, Sandra R Saunders, Sara Ann R Brown, Seneca D Toms, Sharpe, Smith, Sondra L Phillips, Stardust W Mazzariello, State Agency, Stephanie E Hubbard, Susan O Oladeji, T Lindaswart Stewart, Tallman, Theresa L Stewart, Thomas R Binay, Trang N Cox, Trent D Lecoultre, Tyrico K English, Vincent M Williams, Walker, Washington, Watson, Weedb, Williams, Young Kim

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more